FIELD: medicine.
SUBSTANCE: invention is intended for treatment of infectious processes, caused by sensitive microorganisms. The invention discloses application of N-decylpyridinium tetrachloroferrate as antimicrobial preparation.
EFFECT: application of the said compound, possessing antimicrobial action, ensures treatment of infectious processes, caused by sensitive microorganisms.
1 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIMICROBIAL AGENT | 2014 |
|
RU2556509C2 |
| METHOD FOR DETERMINING SENSITIVITY OF BACTERIAL HEMOCULTURES TO ANTIBIOTICS | 2017 |
|
RU2666257C1 |
| BACTERICIDAL NAIL CARE POLISH | 2010 |
|
RU2432158C1 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF DIOXIDINE | 2016 |
|
RU2667974C2 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF BACTERIOLYTIC AND PROTEOLYTIC COMPLEX OF ENZYMES | 2016 |
|
RU2655808C2 |
| ACTIVE BIOLOGICAL SUBSTANCE "INGALIPTUM ACTIVE PLUS", LOCAL ACTION PREPARATION OBTAINED ON ITS BASIS | 2016 |
|
RU2639562C1 |
| ACTIVE BIOLOGICAL SUBSTANCE "CLOROPHYLLIPTUM ACTIVE PLUS", RECEIVED ON ITS BASIS OF LOCAL ACTION PREPARATION AND PACKAGING FOT IT | 2016 |
|
RU2647460C1 |
| ANTIBACTERIAL FILLER FOR FEMALE ABSORBENT ARTICLES, METHOD FOR PRODUCTION AND USES THEREOF | 2005 |
|
RU2286800C1 |
| METHOD FOR SELECTION OF PROBIOTIC AND AUTOPROBIOTIC STRAINS OF MICROORGANISMS BY RESISTANCE TO CYTOSTATICS IN THERAPY OF COLORECTAL CANCER | 2024 |
|
RU2835581C1 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR THE TREATMENT OF PURULENT WOUNDS ON THE BASIS OF FLUOROQUINOLONS (OPTIONS) | 2016 |
|
RU2682171C2 |
